계산
주주 자본 대비 부채 비율 | = | 총 장기 의무1 | ÷ | 주주 자본1 | |
---|---|---|---|---|---|
2023. 12. 31. | 0.02 | = | 426,700) | ÷ | 17,580,400) |
2022. 12. 31. | 0.03 | = | 471,600) | ÷ | 13,912,700) |
2021. 12. 31. | 0.06 | = | 556,700) | ÷ | 10,100,000) |
2020. 12. 31. | 0.07 | = | 581,476) | ÷ | 8,686,815) |
2019. 12. 31. | 0.09 | = | 568,869) | ÷ | 6,085,244) |
2018. 12. 31. | 0.13 | = | 586,821) | ÷ | 4,435,203) |
2017. 12. 31. | 0.29 | = | 583,902) | ÷ | 2,028,579) |
2016. 12. 31. | 0.71 | = | 821,335) | ÷ | 1,156,582) |
2015. 12. 31. | 0.86 | = | 810,981) | ÷ | 939,967) |
2014. 12. 31. | 0.75 | = | 807,141) | ÷ | 1,075,006) |
2013. 12. 31. | 0.36 | = | 489,691) | ÷ | 1,356,405) |
2012. 12. 31. | 0.68 | = | 683,201) | ÷ | 999,180) |
2011. 12. 31. | 0.58 | = | 455,950) | ÷ | 786,843) |
2010. 12. 31. | 1.07 | = | 536,991) | ÷ | 503,973) |
2009. 12. 31. | 0.14 | = | 153,836) | ÷ | 1,096,346) |
2008. 12. 31. | 1.20 | = | 287,500) | ÷ | 238,874) |
2007. 12. 31. | 0.07 | = | 19,997) | ÷ | 271,295) |
2006. 12. 31. | 0.24 | = | 121,747) | ÷ | 505,935) |
2005. 12. 31. | 0.75 | = | 180,097) | ÷ | 239,176) |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위 천
경쟁사와의 비교
Vertex Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023. 12. 31. | 0.02 | 5.73 | 10.37 | 1.35 | 0.34 | 2.34 | 1.09 | 0.43 | 0.93 | 0.04 | 0.81 | 0.10 | 0.75 |
2022. 12. 31. | 0.03 | 3.67 | 10.64 | 1.27 | 0.39 | 1.52 | 1.19 | 0.52 | 0.67 | 0.06 | 0.37 | 0.12 | 0.78 |
2021. 12. 31. | 0.06 | 4.98 | 4.97 | 1.24 | 0.49 | 1.88 | 1.27 | 0.46 | 0.87 | 0.05 | 0.50 | 0.14 | 0.85 |
2020. 12. 31. | 0.07 | 6.58 | 3.51 | 1.34 | 0.53 | 2.94 | 1.73 | 0.56 | 1.26 | 0.05 | 0.63 | 0.24 | 0.63 |
2019. 12. 31. | 0.09 | — | 3.09 | 0.91 | 0.72 | 5.88 | 1.09 | 0.47 | 1.02 | 0.03 | 0.83 | 0.06 | 0.60 |
2018. 12. 31. | 0.13 | — | 2.71 | 0.52 | 0.35 | 1.30 | 1.28 | 0.51 | 0.94 | 0.03 | 0.66 | 0.08 | 0.69 |
2017. 12. 31. | 0.29 | 7.33 | 1.40 | 0.68 | 0.40 | 1.18 | 1.64 | 0.57 | 0.71 | — | 0.60 | 0.11 | 0.83 |
2016. 12. 31. | 0.71 | 7.95 | 1.16 | 0.41 | 0.53 | 0.74 | 1.39 | 0.39 | 0.62 | — | 0.71 | 0.11 | 0.77 |
2015. 12. 31. | 0.86 | 8.03 | 1.12 | 0.47 | 0.54 | 0.55 | 1.20 | 0.28 | 0.59 | — | 0.60 | 0.10 | 0.59 |
2014. 12. 31. | 0.75 | 8.62 | 1.19 | 0.53 | 0.15 | 0.52 | 0.80 | 0.27 | 0.44 | — | 0.51 | 0.18 | 0.71 |
2013. 12. 31. | 0.36 | 3.28 | 1.45 | 0.55 | 0.16 | 0.30 | 0.58 | 0.25 | 0.50 | — | 0.48 | 0.26 | 0.62 |
2012. 12. 31. | 0.68 | 4.66 | 1.39 | 0.54 | 0.28 | 0.37 | 0.88 | 0.25 | 0.39 | — | 0.46 | 0.37 | 0.46 |
2011. 12. 31. | 0.58 | — | 1.13 | 0.34 | 0.31 | 0.52 | 1.13 | 0.34 | 0.32 | — | 0.47 | 0.90 | 0.47 |
2010. 12. 31. | 1.07 | — | 0.56 | 0.35 | 0.21 | 0.56 | 0.59 | 0.30 | 0.33 | — | 0.50 | 0.31 | 0.14 |
2009. 12. 31. | 0.14 | — | 0.47 | 0.43 | 0.25 | 0.70 | 0.18 | 0.29 | 0.30 | — | 0.54 | 0.27 | 0.14 |
2008. 12. 31. | 1.20 | — | 0.50 | 0.55 | 0.27 | 1.55 | 0.31 | 0.28 | 0.33 | — | 0.30 | 0.00 | 0.14 |
2007. 12. 31. | 0.07 | — | 0.63 | 0.59 | 0.41 | 0.37 | 0.38 | 0.22 | 0.32 | — | 0.20 | 0.43 | 0.15 |
2006. 12. 31. | 0.24 | — | 0.48 | 0.74 | 0.37 | 0.34 | 0.77 | 0.17 | 0.39 | — | 0.11 | 0.92 | 0.19 |
2005. 12. 31. | 0.75 | — | 0.19 | 0.77 | 0.21 | 0.60 | 0.10 | 0.07 | 0.45 | — | 0.27 | 1.75 | 0.21 |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Vertex Pharmaceuticals Inc. | 제약, 생명공학 및 생명과학 | |
---|---|---|
2023. 12. 31. | 0.02 | 0.98 |
2022. 12. 31. | 0.03 | 0.79 |
2021. 12. 31. | 0.06 | 0.92 |
2020. 12. 31. | 0.07 | 1.14 |
2019. 12. 31. | 0.09 | 1.10 |
2018. 12. 31. | 0.13 | 0.94 |
2017. 12. 31. | 0.29 | 0.88 |
2016. 12. 31. | 0.71 | 0.79 |
2015. 12. 31. | 0.86 | 0.68 |
2014. 12. 31. | 0.75 | 0.55 |
2013. 12. 31. | 0.36 | 0.52 |
2012. 12. 31. | 0.68 | 0.51 |
2011. 12. 31. | 0.58 | 0.46 |
2010. 12. 31. | 1.07 | 0.39 |
2009. 12. 31. | 0.14 | 0.39 |
2008. 12. 31. | 1.20 | 0.37 |
2007. 12. 31. | 0.07 | 0.30 |
2006. 12. 31. | 0.24 | 0.25 |
2005. 12. 31. | 0.75 | 0.29 |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
업계와의 비교: 의료
Vertex Pharmaceuticals Inc. | 의료 | |
---|---|---|
2023. 12. 31. | 0.02 | 0.81 |
2022. 12. 31. | 0.03 | 0.72 |
2021. 12. 31. | 0.06 | 0.78 |
2020. 12. 31. | 0.07 | 0.90 |
2019. 12. 31. | 0.09 | 0.91 |
2018. 12. 31. | 0.13 | 0.87 |
2017. 12. 31. | 0.29 | 0.79 |
2016. 12. 31. | 0.71 | 0.75 |
2015. 12. 31. | 0.86 | 0.68 |
2014. 12. 31. | 0.75 | 0.52 |
2013. 12. 31. | 0.36 | 0.49 |
2012. 12. 31. | 0.68 | 0.51 |
2011. 12. 31. | 0.58 | 0.45 |
2010. 12. 31. | 1.07 | 0.41 |
2009. 12. 31. | 0.14 | 0.41 |
2008. 12. 31. | 1.20 | 0.41 |
2007. 12. 31. | 0.07 | 0.36 |
2006. 12. 31. | 0.24 | 0.33 |
2005. 12. 31. | 0.75 | 0.30 |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).